ZA864525B - Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained - Google Patents

Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained

Info

Publication number
ZA864525B
ZA864525B ZA864525A ZA864525A ZA864525B ZA 864525 B ZA864525 B ZA 864525B ZA 864525 A ZA864525 A ZA 864525A ZA 864525 A ZA864525 A ZA 864525A ZA 864525 B ZA864525 B ZA 864525B
Authority
ZA
South Africa
Prior art keywords
ypsilon
interferon
vector
expression
product obtained
Prior art date
Application number
ZA864525A
Inventor
Therese Faure
Paul Sondermeyer
Werner Altenburger
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of ZA864525B publication Critical patent/ZA864525B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA864525A 1985-06-18 1986-06-17 Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained ZA864525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8509225A FR2583429B1 (en) 1985-06-18 1985-06-18 INTERFERON U EXPRESSION VECTOR IN MAMMALIAN CELLS, PROCESS FOR IMPLEMENTING SAME AND PRODUCT OBTAINED, AND PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON U

Publications (1)

Publication Number Publication Date
ZA864525B true ZA864525B (en) 1987-03-25

Family

ID=9320362

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864525A ZA864525B (en) 1985-06-18 1986-06-17 Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained

Country Status (7)

Country Link
EP (1) EP0206920A1 (en)
JP (1) JPS63500003A (en)
AU (1) AU5957986A (en)
DK (1) DK79887D0 (en)
FR (1) FR2583429B1 (en)
WO (1) WO1986007609A1 (en)
ZA (1) ZA864525B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
ZA875681B (en) * 1986-08-01 1988-04-27 Commw Scient Ind Res Org Recombinant vaccine
JPS6363381A (en) * 1986-09-04 1988-03-19 Kokuritsu Yobou Eisei Kenkyusho Recombinant vaccinia virus
FR2622456B1 (en) * 1987-10-29 1990-02-02 Transgene Sa RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS
FR2632863B2 (en) * 1987-10-29 1990-08-31 Transgene Sa RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
EP0469089B1 (en) * 1989-04-18 1997-11-19 Applied Biotechnology, Inc. Generation of hybrid genes and proteins by virus-mediated recombination
GB8915870D0 (en) * 1989-07-11 1989-08-31 Nat Res Dev Dna coding for a polypeptide signal sequence in vaccinia virus
DE4002521A1 (en) * 1990-01-29 1991-08-01 Immuno Ag Recombinant plasmids for pox virus transformation - contg. multifunctional DNA sequence cassette to facilitate cloning of foreign DNA
FR2710536B1 (en) * 1993-09-29 1995-12-22 Transgene Sa Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response.
US6093700A (en) 1995-05-11 2000-07-25 Thomas Jefferson University Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF
CA2190290C (en) * 1994-05-13 2011-07-05 Michael J. Mastrangelo A method of inducing an immune response using vaccinia virus recombinants
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
EP2325321A1 (en) 1999-05-28 2011-05-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
PT1649023E (en) * 2003-07-21 2008-11-20 Transgene Sa Polypeptide having an improved cytosine deaminase activity
CA2531773A1 (en) 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
US8470977B2 (en) 2008-03-14 2013-06-25 Transgene S.A. Antibody against the CSF-1R
BRPI1006179A2 (en) 2009-01-13 2016-02-23 Transgène S A use of a mitochondrial nucleic acid fraction, adjuvant composition, vaccine composition, and part kit
WO2010117786A1 (en) 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
JP5897464B2 (en) 2009-08-07 2016-03-30 トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． Composition for treating HBV infection
KR20130075732A (en) 2010-03-30 2013-07-05 마운트 시나이 스쿨 오브 메디슨 Influenza virus vaccines and uses thereof
AU2012312529B2 (en) 2011-09-20 2018-01-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
EP2788021B1 (en) 2011-12-09 2017-01-18 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
CN104870477B (en) 2012-10-23 2018-10-09 爱默蕾大学 GM-CSF and IL-4 conjugates, composition and relative method
WO2014099931A1 (en) 2012-12-18 2014-06-26 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
CA3044074A1 (en) 2016-11-16 2018-05-24 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
WO2018204534A1 (en) 2017-05-02 2018-11-08 Immunomic Therapeutics, Inc. Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
EP3793595A1 (en) 2018-05-15 2021-03-24 Immunomic Therapeutics, Inc. Improved lamp constructs comprising allergens
CN114641306A (en) 2019-10-18 2022-06-17 免疫治疗有限公司 Improved LAMP constructs comprising cancer antigens
WO2023201201A1 (en) 2022-04-10 2023-10-19 Immunomic Therapeutics, Inc. Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
AU570940B2 (en) * 1982-11-30 1988-03-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for producing poxvirus recombinants for expression offoreign genes

Also Published As

Publication number Publication date
DK79887A (en) 1987-02-17
FR2583429B1 (en) 1989-11-03
AU5957986A (en) 1987-01-13
DK79887D0 (en) 1987-02-17
JPS63500003A (en) 1988-01-07
FR2583429A1 (en) 1986-12-19
EP0206920A1 (en) 1986-12-30
WO1986007609A1 (en) 1986-12-31

Similar Documents

Publication Publication Date Title
ZA864525B (en) Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained
IL73942A0 (en) Method and vector for the production of polypeptides in insect cells
GB2197321B (en) Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
GB2173118B (en) Sparger and apparatus for and method of growing cells
DE3568999D1 (en) Method and apparatus for incubating cells
HUT39019A (en) Solid phase process and equipment for the determination of sequence in nucleinic acid fragments
HUT40712A (en) Method of preparing electrode and application of the electrode in electrochemical process
AU1685288A (en) Cell culture of anchorage dependent cells, materials and products
AU5452986A (en) Fluidized bioreactor and cell cultivation process
ZA8410146B (en) Continuous bioreactor and process
DE3568798D1 (en) Cell and tissue culture process and apparatus
EP0095804A3 (en) Process and fermenter for cultivating tissue cells
IL82475A0 (en) Enhanced expression of human interleukin-2 in mammalian cells
AU3102289A (en) Regulation of expression in mammalian cells
EP0300588A3 (en) Cell culturing apparatus and method
GB2124652B (en) Production of single cell protein and microorganisms for use therein
EP0205399A3 (en) Amperometric cell and method amperometric cell and method
PT83301B (en) Expression of superoxide dismutase in eukaryotic cells and process for obtaining the same
GB2173197B (en) Method for making silylaroylhalides and reaction products
IL72823A (en) Cell culture system consisting of basic modules and method for biosynthesis of cellular products using it
IL86354A0 (en) Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof
EP0135996A3 (en) Improvements in or relating to containers and methods of, and apparatus for, manufacturing containers
DE3662279D1 (en) Process and apparatus for the readjustment of the operational setting in an electrolysis cell
EP0116411A3 (en) Dna expression vectors useful in bacillus cells
EP0229289A3 (en) Method of culturing animal cells